학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 10건 | 목록
1~20
Academic Journal
Lubrano S; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cervantes-Villagrana RD; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Arang N; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA.; Cardenas-Alcoser ES; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Sato K; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cuesta-Margolles G; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Paradis JS; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Acosta M; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Gutkind JS; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Paradis JS; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada.; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, H3T 1J4, Canada.; Feng X; Interfaculty Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, Lausanne, CH-1015, Switzerland.; Department of Structural Biology, Van Andel Institute, Grand Rapids, MI, USA.; Murat B; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada.; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, H3T 1J4, Canada.; Jefferson RE; Interfaculty Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, Lausanne, CH-1015, Switzerland.; Sokrat B; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada.; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, H3T 1J4, Canada.; Szpakowska M; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.; Hogue M; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, H3T 1J4, Canada.; Bergkamp ND; Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Sciences, Vrije Universiteit, Amsterdam, The Netherlands.; Heydenreich FM; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada.; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, H3T 1J4, Canada.; Smit MJ; Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Sciences, Vrije Universiteit, Amsterdam, The Netherlands.; Chevigné A; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.; Bouvier M; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada. michel.bouvier@umontreal.ca.; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, H3T 1J4, Canada. michel.bouvier@umontreal.ca.; Barth P; Interfaculty Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, Lausanne, CH-1015, Switzerland. patrick.barth@epfl.ch.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Burghi V; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Paradis JS; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Officer A; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Adame-Garcia SR; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Wu X; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Matthees ESF; Institut für Molekulare Zellbiologie, CMB - Center for Molecular Biomedicine, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Jena, Germany.; Barsi-Rhyne B; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, USA.; Ramms DJ; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Clubb L; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Acosta M; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Tamayo P; Moores Cancer Center, University of California San Diego, La Jolla, California, USA.; Bouvier M; Department of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer, Université de Montréal, Québec, Canada.; Inoue A; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.; von Zastrow M; Department of Psychiatry and Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, USA.; Hoffmann C; Institut für Molekulare Zellbiologie, CMB - Center for Molecular Biomedicine, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Jena, Germany.; Gutkind JS; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA. Electronic address: sgutkind@health.ucsd.edu.
Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE
Academic Journal
Epping-Jordan MP; Addex Therapeutics, S.A., Chemin des Mines 9, 1202 Geneva, Switzerland.; Girard F; Addex Therapeutics, S.A., Chemin des Mines 9, 1202 Geneva, Switzerland.; Bessis AS; Addex Therapeutics, S.A., Chemin des Mines 9, 1202 Geneva, Switzerland.; Mutel V; Addex Therapeutics, S.A., Chemin des Mines 9, 1202 Geneva, Switzerland.; Boléa C; Addex Therapeutics, S.A., Chemin des Mines 9, 1202 Geneva, Switzerland.; Derouet F; Addex Therapeutics, S.A., Chemin des Mines 9, 1202 Geneva, Switzerland.; Bessif A; Addex Therapeutics, S.A., Chemin des Mines 9, 1202 Geneva, Switzerland.; Mingard B; Addex Therapeutics, S.A., Chemin des Mines 9, 1202 Geneva, Switzerland.; Barbier S; Addex Therapeutics, S.A., Chemin des Mines 9, 1202 Geneva, Switzerland.; Paradis JS; Addex Therapeutics, S.A., Chemin des Mines 9, 1202 Geneva, Switzerland.; Rocher JP; Addex Therapeutics, S.A., Chemin des Mines 9, 1202 Geneva, Switzerland.; Lütjens R; Addex Therapeutics, S.A., Chemin des Mines 9, 1202 Geneva, Switzerland.; Kalinichev M; Addex Therapeutics, S.A., Chemin des Mines 9, 1202 Geneva, Switzerland.; Poli S; Addex Therapeutics, S.A., Chemin des Mines 9, 1202 Geneva, Switzerland.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE
Academic Journal
Beautrait A; Department of Biochemistry, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Quebec, Canada H3T 1J4.; Paradis JS; Department of Molecular Biology Program, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Quebec, Canada H3T 1J4.; Zimmerman B; Department of Pharmacology and Therapeutics, Research Institute of McGill University Health Centre (RI-MUHC), McGill University, Montréal, Quebec, Canada H4A 3J1.; Giubilaro J; Department of Pharmacology and Therapeutics, Research Institute of McGill University Health Centre (RI-MUHC), McGill University, Montréal, Quebec, Canada H4A 3J1.; Nikolajev L; Department of Medicine, Research Institute of McGill University Health Centre (RI-MUHC), McGill University, Montréal, Quebec, Canada H4A 3J1.; Armando S; Department of Medicine, Research Institute of McGill University Health Centre (RI-MUHC), McGill University, Montréal, Quebec, Canada H4A 3J1.; Kobayashi H; Department of Biochemistry, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Quebec, Canada H3T 1J4.; Yamani L; Department of Medicine, Research Institute of McGill University Health Centre (RI-MUHC), McGill University, Montréal, Quebec, Canada H4A 3J1.; Namkung Y; Department of Medicine, Research Institute of McGill University Health Centre (RI-MUHC), McGill University, Montréal, Quebec, Canada H4A 3J1.; Heydenreich FM; Laboratory of Biomolecular Research, Department of Biology and Chemistry, Paul Scherrer Institut,5232 Villigen PSI, Switzerland, Switzerland.; Khoury E; Department of Medicine, Research Institute of McGill University Health Centre (RI-MUHC), McGill University, Montréal, Quebec, Canada H4A 3J1.; Audet M; Department of Biochemistry, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Quebec, Canada H3T 1J4.; Roux PP; Department of Pathology and Cellular Biology, Institute of Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Quebec, Canada H3T 1J4.; Veprintsev DB; Laboratory of Biomolecular Research, Department of Biology and Chemistry, Paul Scherrer Institut,5232 Villigen PSI, Switzerland, Switzerland.; Laporte SA; Department of Pharmacology and Therapeutics, Research Institute of McGill University Health Centre (RI-MUHC), McGill University, Montréal, Quebec, Canada H4A 3J1.; Department of Medicine, Research Institute of McGill University Health Centre (RI-MUHC), McGill University, Montréal, Quebec, Canada H4A 3J1.; Department of Anatomy and Cell Biology, Research Institute of McGill University Health Centre (RI-MUHC), McGill University, Montréal, Quebec, Canada H4A 3J1.; Bouvier M; Department of Biochemistry, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Quebec, Canada H3T 1J4.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Paradis JS; Acosta M; Saddawi-Konefka R; Kishore A; Lubrano S; Gomes F; Arang N; Tiago M; Coma S; Wu X; Ford K; Day CP; Merlino G; Mali P; Pachter JA; Sato T; Aplin AE; Gutkind JS
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Paradis JS; Moores Cancer Center, University of California San Diego, La Jolla, California.; Acosta M; Moores Cancer Center, University of California San Diego, La Jolla, California.; Saddawi-Konefka R; Moores Cancer Center, University of California San Diego, La Jolla, California.; Department of Surgery, Division of Otolaryngology-Head and Neck Surgery, University of California San Diego, La Jolla, California.; Kishore A; Moores Cancer Center, University of California San Diego, La Jolla, California.; Gomes F; Moores Cancer Center, University of California San Diego, La Jolla, California.; Arang N; Moores Cancer Center, University of California San Diego, La Jolla, California.; Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, California.; Tiago M; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Coma S; Verastem Oncology, Needham, Massachusetts.; Lubrano S; Moores Cancer Center, University of California San Diego, La Jolla, California.; Wu X; Moores Cancer Center, University of California San Diego, La Jolla, California.; Ford K; Department of Bioengineering, University of California San Diego, San Diego, California.; Day CP; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, NCI, NIH, Maryland.; Merlino G; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, NCI, NIH, Maryland.; Mali P; Department of Bioengineering, University of California San Diego, San Diego, California.; Pachter JA; Verastem Oncology, Needham, Massachusetts.; Sato T; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.; Aplin AE; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.; Gutkind JS; Moores Cancer Center, University of California San Diego, La Jolla, California. sgutkind@ucsd.edu.; Department of Pharmacology, University of California San Diego, La Jolla, California.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Blondel-Tepaz E; Inserm, U1016, Institut Cochin, Paris, France.; CNRS, UMR8104, Paris, France.; Université de Paris, Paris, France.; Leverve M; Inserm, U1016, Institut Cochin, Paris, France.; CNRS, UMR8104, Paris, France.; Université de Paris, Paris, France.; Sokrat B; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada.; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, Canada.; Paradis JS; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, Canada.; Molecular Biology Program, Université de Montréal, Montréal, QC, Canada.; Kosic M; Leslie Dan Faculty of Pharmacy and Department of Biochemistry, University of Toronto, Toronto, ON, Canada.; Saha K; Inserm, U1016, Institut Cochin, Paris, France.; CNRS, UMR8104, Paris, France.; Université de Paris, Paris, France.; Auffray C; Inserm, U1016, Institut Cochin, Paris, France.; CNRS, UMR8104, Paris, France.; Université de Paris, Paris, France.; Lima-Fernandes E; Inserm, U1016, Institut Cochin, Paris, France.; CNRS, UMR8104, Paris, France.; Université de Paris, Paris, France.; Zamborlini A; Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay, Gif-sur-Yvette, France.; Poupon A; PRC, INRA, CNRS, IFCE, Université de Tours, Nouzilly, France.; Gaboury L; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, Canada.; Department of Pathology and Cell Biology, IRIC, Université de Montréal, Montréal, QC, Canada.; Findlay J; Institute of Cardiovascular and Medical Sciences, College of Veterinary, Medical and Life Sciences, University of Glasgow, Glasgow, UK.; Baillie GS; Institute of Cardiovascular and Medical Sciences, College of Veterinary, Medical and Life Sciences, University of Glasgow, Glasgow, UK.; Enslen H; Inserm, U1016, Institut Cochin, Paris, France.; CNRS, UMR8104, Paris, France.; Université de Paris, Paris, France.; Bouvier M; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, Canada.; Molecular Biology Program, Université de Montréal, Montréal, QC, Canada.; Angers S; Leslie Dan Faculty of Pharmacy and Department of Biochemistry, University of Toronto, Toronto, ON, Canada.; Marullo S; Inserm, U1016, Institut Cochin, Paris, France.; CNRS, UMR8104, Paris, France.; Université de Paris, Paris, France.; Scott MGH; Inserm, U1016, Institut Cochin, Paris, France. mark.scott@inserm.fr.; CNRS, UMR8104, Paris, France. mark.scott@inserm.fr.; Université de Paris, Paris, France. mark.scott@inserm.fr.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE
Academic Journal
Lima-Fernandes E; 1] Department of Endocrinology, Metabolism and Diabetes, Inserm, U1016, Institut Cochin, 27 rue du Faubourg St Jaques, Paris 75014, France [2] CNRS, UMR8104, Paris 75014, France [3] University Paris Descartes, Sorbonne Paris Cité, Paris 75014, France [4].; Misticone S; 1] Department of Endocrinology, Metabolism and Diabetes, Inserm, U1016, Institut Cochin, 27 rue du Faubourg St Jaques, Paris 75014, France [2] CNRS, UMR8104, Paris 75014, France [3] University Paris Descartes, Sorbonne Paris Cité, Paris 75014, France [4].; Boularan C; 1] Department of Endocrinology, Metabolism and Diabetes, Inserm, U1016, Institut Cochin, 27 rue du Faubourg St Jaques, Paris 75014, France [2] CNRS, UMR8104, Paris 75014, France [3] University Paris Descartes, Sorbonne Paris Cité, Paris 75014, France [4].; Paradis JS; 1] Molecular Biology Program, Department of Biochemistry, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada H3C 3J7 [2] Department of Pathology and Cell Biology, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada H3C 3J7 [3].; Enslen H; 1] Department of Endocrinology, Metabolism and Diabetes, Inserm, U1016, Institut Cochin, 27 rue du Faubourg St Jaques, Paris 75014, France [2] CNRS, UMR8104, Paris 75014, France [3] University Paris Descartes, Sorbonne Paris Cité, Paris 75014, France.; Roux PP; 1] Molecular Biology Program, Department of Biochemistry, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada H3C 3J7 [2] Department of Pathology and Cell Biology, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada H3C 3J7.; Bouvier M; 1] Molecular Biology Program, Department of Biochemistry, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada H3C 3J7 [2] Department of Pathology and Cell Biology, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada H3C 3J7.; Baillie GS; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK.; Marullo S; 1] Department of Endocrinology, Metabolism and Diabetes, Inserm, U1016, Institut Cochin, 27 rue du Faubourg St Jaques, Paris 75014, France [2] CNRS, UMR8104, Paris 75014, France [3] University Paris Descartes, Sorbonne Paris Cité, Paris 75014, France.; Scott MG; 1] Department of Endocrinology, Metabolism and Diabetes, Inserm, U1016, Institut Cochin, 27 rue du Faubourg St Jaques, Paris 75014, France [2] CNRS, UMR8104, Paris 75014, France [3] University Paris Descartes, Sorbonne Paris Cité, Paris 75014, France.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Paradis JS; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3C 1J4, Canada;; Ly S; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3C 1J4, Canada; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC H3C IJ4, Canada;; Blondel-Tepaz É; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3C 1J4, Canada;; Galan JA; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3C 1J4, Canada; Department of Pathology and Cell Biology, Université de Montréal, Montréal, QC H3C IJ4, Canada;; Beautrait A; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3C 1J4, Canada;; Scott MG; Institut Cochin, Inserm U1016, CNRS UMR8104, Université Paris Descartes, Sorbonne Paris Cité, 75014 Paris, France.; Enslen H; Institut Cochin, Inserm U1016, CNRS UMR8104, Université Paris Descartes, Sorbonne Paris Cité, 75014 Paris, France.; Marullo S; Institut Cochin, Inserm U1016, CNRS UMR8104, Université Paris Descartes, Sorbonne Paris Cité, 75014 Paris, France.; Roux PP; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3C 1J4, Canada; Department of Pathology and Cell Biology, Université de Montréal, Montréal, QC H3C IJ4, Canada; philippe.roux@umontreal.ca michel.bouvier@umontreal.ca.; Bouvier M; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3C 1J4, Canada; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC H3C IJ4, Canada; philippe.roux@umontreal.ca michel.bouvier@umontreal.ca.
Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Paradis, Justine S
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어